CANC vs. COMT
CANC (Tema Oncology ETF) and COMT (iShares GSCI Commodity Dynamic Roll Strategy ETF) are both exchange-traded funds - CANC is a Health & Biotech Equities fund actively managed by Tema, while COMT is a Commodities fund tracking the S&P GSCI Dynamic Roll (USD) Total Return Index. CANC is actively managed, while COMT is passively managed. Over the past 3 years, CANC returned 108.39%/yr vs 12.71%/yr for COMT. At a 0.04 correlation, their price movements are largely independent. CANC charges 0.75%/yr vs 0.48%/yr for COMT.
Performance
CANC vs. COMT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CANC achieves a 16.66% return, which is significantly lower than COMT's 30.19% return.
CANC
- 1D
- -0.97%
- 1M
- 8.94%
- 6M
- 10.55%
- YTD
- 16.66%
- 1Y
- 54.48%
- 3Y*
- 108.39%
- 5Y*
- —
- 10Y*
- —
COMT
- 1D
- -0.49%
- 1M
- 2.53%
- 6M
- 26.18%
- YTD
- 30.19%
- 1Y
- 33.20%
- 3Y*
- 12.71%
- 5Y*
- 11.75%
- 10Y*
- 8.33%
CANC vs. COMT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CANC Tema Oncology ETF | 16.66% | 42.92% | -5.37% | 510.51% | -85.34% | -55.35% |
COMT iShares GSCI Commodity Dynamic Roll Strategy ETF | 30.19% | 6.07% | 5.96% | -6.56% | 19.45% | 2.40% |
Correlation
The correlation between CANC and COMT is -0.25, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.10 |
Correlation (All Time) Calculated using the full available price history since Sep 30, 2021 | 0.04 |
The correlation between CANC and COMT shifts across timeframes, from -0.25 (1 year) to 0.04 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CANC vs. COMT — Risk / Return Rank
CANC
COMT
CANC vs. COMT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tema Oncology ETF (CANC) and iShares GSCI Commodity Dynamic Roll Strategy ETF (COMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CANC | COMT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.87 | ||
| Sortino ratioReturn per unit of downside risk | +1.29 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.27 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | 5.89 | 1.90 | +3.99 |
| Martin ratioReturn relative to average drawdown | 15.89 | 6.35 | +9.54 |
Loading charts...
Drawdowns
CANC vs. COMT - Drawdown Comparison
The maximum CANC drawdown since its inception was -97.53%, which is greater than COMT's maximum drawdown of -51.89%. Use the drawdown chart below to compare losses from any high point for CANC and COMT.
Loading charts...
Drawdown Indicators
| CANC | COMT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.53% | -51.89% | -45.64% |
Max Drawdown (1Y)Largest decline over 1 year | -9.30% | -17.57% | +8.27% |
Max Drawdown (3Y)Largest decline over 3 years | -30.27% | -17.57% | -12.70% |
Max Drawdown (5Y)Largest decline over 5 years | — | -29.00% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -39.22% | — |
Current DrawdownCurrent decline from peak | -51.64% | -11.28% | -40.36% |
Average DrawdownAverage peak-to-trough decline | -72.65% | -23.95% | -48.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.44% | 5.24% | -1.80% |
Volatility
CANC vs. COMT - Volatility Comparison
Tema Oncology ETF (CANC) has a higher volatility of 6.45% compared to iShares GSCI Commodity Dynamic Roll Strategy ETF (COMT) at 5.91%. This indicates that CANC's price experiences larger fluctuations and is considered to be riskier than COMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CANC | COMT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.45% | 5.91% | +0.54% |
Volatility (6M)Calculated over the trailing 6-month period | 16.40% | 19.67% | -3.27% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.74% | 21.54% | +1.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 276.80% | 21.20% | +255.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 276.80% | 18.85% | +257.95% |
CANC vs. COMT - Expense Ratio Comparison
CANC has a 0.75% expense ratio, which is higher than COMT's 0.48% expense ratio.
Dividends
CANC vs. COMT - Dividend Comparison
CANC's dividend yield for the trailing twelve months is around 0.05%, less than COMT's 5.95% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CANC Tema Oncology ETF | 0.05% | 0.06% | 3.00% | 0.56% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
COMT iShares GSCI Commodity Dynamic Roll Strategy ETF | 5.95% | 7.74% | 4.90% | 5.19% | 29.79% | 17.79% | 0.36% | 2.61% | 11.65% | 5.16% | 0.52% | 1.44% |
Frequently Asked Questions
CANC and COMT have a correlation of -0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CANC has higher volatility (6.45%) compared to COMT (5.91%). In terms of maximum drawdown, CANC dropped -97.53% vs COMT's -51.89%.
On 3-year performance, CANC leads with 108.39% vs 12.71% for COMT. On fees, COMT is cheaper at 0.48% per year. On volatility, COMT has been the lower-risk option at 5.91%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, CANC has performed better with a 108.39% return vs 12.71%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
COMT is cheaper with a 0.48% expense ratio, compared with 0.75% for CANC.
COMT has the higher dividend yield at 5.95%, compared with 0.05% for CANC.
CANC is categorized as Health & Biotech Equities, while COMT is Commodities. They also come from different issuers: Tema and iShares. Their fees differ too: 0.75% for CANC and 0.48% for COMT.
CANC currently has the higher Sharpe Ratio (2.42 vs 1.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CANC and COMT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer